ENTITY
Sirnaomics

Sirnaomics (2257 HK)

44
Analysis
Health Care • Hong Kong
Sirnaomics is an RNA therapeutics biopharmaceutical company that discovers and develops innovative drugs for indications with unmet medical needs. The company leverages its proprietary polypeptide nanoparticle (PNP) and GalNAc RNAi platforms (GalAhead™) to build a pipeline of drug candidates, including STP705 and STP707 for oncology and fibrosis, and STP122G for anticoagulant therapies. Headquartered in Gaithersburg, MD, United States, the company was founded in 2007.
more
Company Event • 26 Mar 2027 17:00 • Upcoming
Add To Calendar

H2 2026

Company Event • 28 Aug 2026 17:00 • Upcoming
Add To Calendar

H1 2026

Company Event • 27 Mar 2026 17:00 • Upcoming
Add To Calendar

H2 2025

Company Event • 29 Aug 2025 17:00 • Upcoming
Add To Calendar

H1 2025

Company Event • 27 Mar 2025 16:00 • Upcoming
Add To Calendar

H2 2024

x